Clinical Research, Pharma & Healthcare FinancingEmalex Biosciences’ Lead Candidate Hits Endpoints in TS StudyBusiness WireFebruary 26, 2025August 1, 2025 by Business WireFebruary 26, 2025August 1, 20250121 Topline data from Phase 3 study in patients with Tourette syndrome shows statistical significance between ecopipam and placebo for both the primary efficacy endpoint in...
